ask="24.50"
ask_size="100"
average_daily_volume="109728"
bid="N/A"
bid_size="N/A"
book_value="3.28"
change="+0.05"
change_from_200_day_moving_average="-3.66"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-11.95"
change_From_52_week_low="1.25"
change_in_percent="+0.88%"
close="5.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.54"
ebitda="-19.40M"
eps_estimate_current_year="-2.76"
eps_estimate_next_quarter="-0.88"
eps_estimate_next_year="-2.78"
ex_dividend_date="N/A"
float_shares="6447000"
high="5.88"
high_52_weeks="17.70"
last_trade_date="3/7/2017"
last_trade_price="5.75"
last_trade_size="2631"
last_trade_time="4:00pm"
low="5.51"
low_52_weeks="4.50"
market_capitalization="44.95M"
moving_average_200_day="9.41"
moving_average_50_day="5.67"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.66"
open="5.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-38.87%"
percent_change_from_50_day_moving_average="+1.41%"
percent_change_from_52_week_high="-67.51%"
percent_change_from_52_week_low="+27.78%"
previous_close="5.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.74"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.53"
stock_exchange="NCM"
symbol="TRIL"
volume="34666"
weeks_range_52="4.50 - 17.70"
